Statins administration in diabetic dyslipidemia
Showing 1 - 25 of >10,000
Acute Myocardial Infarction, Glucose Metabolism Disorders Trial in Beijing (Pitavastatin, Atorvastatin)
Recruiting
- Acute Myocardial Infarction
- Glucose Metabolism Disorders
-
Beijing, Beijing, ChinaFuwai Hospital
May 7, 2022
Metabolism Disorder, Lipid, Metabolism Disorder, Glucose Trial (Xuezhikang Capsule, Atorvastatin Calcium Tablets)
Not yet recruiting
- Metabolism Disorder, Lipid
- Metabolism Disorder, Glucose
- Xuezhikang Capsule
- Atorvastatin Calcium Tablets
- (no location specified)
Feb 9, 2022
A Combination Drug Including Fimasartan and Statins in
Completed
- Hypertension and Dyslipidemia
- Combination drug containing fimasartan and statins
-
Gwangju, Jebong-ro, Jangseong-eup, Jangseong-gun, Korea, Republic ofChonnam National University Hospital
Nov 15, 2022
Intracerebral Hemorrhage Trial in Szczecin (Atorvastatin, Rosuvastatin, No drugs)
Completed
- Intracerebral Hemorrhage
- Atorvastatin
- +2 more
-
Szczecin, West Pomeranian, PolandPomeranian Medical University
Oct 16, 2023
Diabetes, Type 2, Dyslipidemias, Hypertension Trial in Cairo (Puritans Pride Turmeric curcumin® 500 mg)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Puritans Pride Turmeric curcumin® 500 mg
-
Cairo, EgyptDemerdash Hospital, Faculty of Medicine, Ain Shams University
Mar 1, 2023
Breast Cancer, Early-stage Breast Cancer Trial in Baltimore (Prescreening, Screening and Enrollment, Baseline)
Recruiting
- Breast Cancer
- Early-stage Breast Cancer
- Prescreening
- +8 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 16, 2022
Dyslipidemia and Diabetic Retinopathy
Recruiting
- Diabetic Retinopathy
- Dyslipidemia
- 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
- Healthy Controls 15 age matched control subjects
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 11, 2022
Status of Dyslipidemia Following Administration of Statin and
Recruiting
- Dyslipidemias
- Statin+Ezetimibe compound
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Nov 7, 2022
Diabetic Foot Ulcer Trial in Hadera (device, diagnostic test, other)
Recruiting
- Diabetic Foot Ulcer
- Study treatment administration (TriO FITT)
- +10 more
-
Hadera, IsraelHilel Yafe Medical Center
Aug 21, 2023
OLOMAX for Blood Pressure and Low-density Lipoprotein
Recruiting
- Hypertension
- Dyslipidemias
- Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
-
Seoul, Korea, Republic ofSeoul St.Mary's Hospital
Dec 13, 2022
Pre-diabetes Trial in Botucatú (Eriomin, Washout, Placebo)
Recruiting
- Pre-diabetes
- Eriomin
- +2 more
-
Botucatú, SP, BrazilCentro de Estudos e Praticas em Nutrição (CEPRAN)
Aug 21, 2023
Epicardial Fat Thickness in Children With Familial Dyslipidemia
Not yet recruiting
- Dyslipidemia
- echoCARDIOGRAPHY
- (no location specified)
Oct 22, 2023
Diabetes, Type 2 Trial in Palermo (Liraglutide injection, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Liraglutide injection
- Insulin Glargine
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
May 3, 2022
SGLT-2 Inhibitors in the Treatment of Ascites
Recruiting
- Ascites Hepatic
- +2 more
- SGLT2 inhibitor
-
Palermo, Italy
- +1 more
Aug 11, 2023
Diabetic Foot, Diabetic Foot Ulcer, Diabetic Foot Ulcer Neuropathic Trial in Jerusalem (hOMSC200, Placebo)
Recruiting
- Diabetic Foot
- +2 more
- hOMSC200
- Placebo
-
Jerusalem, IsraelShaare Zedek Medical Center
Aug 15, 2023
Dyslipidemias Trial in Ankara (Calisthenic Exercises, Aerobic Exercises)
Not yet recruiting
- Dyslipidemias
- Calisthenic Exercises
- Aerobic Exercises
-
Ankara, TurkeyHacettepe University
Aug 23, 2023
Diabetic Macular Edema Trial in Beijing (ASKG712)
Not yet recruiting
- Diabetic Macular Edema
- ASKG712
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Jul 12, 2023
Dyslipidemias, Non-Alcoholic Fatty Liver Disease Trial in San Antonio (LY3885125, Placebo)
Recruiting
- Dyslipidemias
- Non-Alcoholic Fatty Liver Disease
- LY3885125
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials, Early Phase Services LLC
Aug 18, 2023
Diabetic Macular Edema Trial in Tianjin (FT-003)
Recruiting
- Diabetic Macular Edema
- FT-003
-
Tianjin, Tianjin,China, ChinaTianjin Medical University Eye Hospital
Jun 14, 2023
Dyslipidemia, Hypertension Trial in Seoul (LivaloVA, LivaloV, VA)
Recruiting
- Dyslipidemia
- Hypertension
- LivaloVA
- +2 more
-
Seoul, Korea, Korea, Republic ofGangdong Sacred Heart Hospital
Apr 10, 2022
Diabetic Ketoacidosis, Type 1 Diabetes, Type 2 Diabetes Trial in Cleveland (Early Glargine, Late Glargine, IV insulin infusion)
Terminated
- Diabetic Ketoacidosis
- +2 more
- Early Glargine
- +3 more
-
Cleveland, OhioCleveland Clinic Fairview Hospital
Aug 1, 2022
Type 1 Diabetes, Coronary Artery Calcification Trial (Coronary Artery Calcification Realization)
Recruiting
- Type 1 Diabetes
- Coronary Artery Calcification
- Coronary Artery Calcification Realization
-
Poitiers, FranceC.H.U. de Poitiers
Oct 10, 2022